Astrazeneca committed to accelerating vaccine supply to Africa
Pharmaceutical and biotechnology firm, Astrazeneca, has said it is committed to expanding and accelerating vaccine supply to the African region through 2022 and beyond to help governments reach their vaccination targets. The firm, in a statement on Tuesday, said, an estimated 70 million doses have reached sub-Saharan Africa, making the AstraZeneca vaccine one of the…